Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Professional Survey Report 2018

Publisher : XYZResearch Publication Date : Jul 10, 2018

Number of Pages : 102 Subcategory : Medical Devices
Single User $ 2800
Global User $ 5500

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    GENFIT
    Gilead
    AstraZeneca
    Novartis AG
    Bristol-Myers Squibb
    Allergan Novo Nordisk A/S
    Boehringer Ingelheim GmbH
    Pfizer
    ...

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Serum biomarkers
    Hepatic fibrosis biomarkers
    Apoptosis biomarkers
    Oxidative stress biomarkers
    Others

    By Application, the market can be split into
    Pharma & CRO Industry
    Hospitals
    Diagnostic Labs
    Academic Research Institutes

    By Regions, this report covers (we can add the regions/countries as you want)
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

    If you have any special requirements, please let us know and we will offer you the report as you want.

  • Table of Content

    Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Professional Survey Report 2018

    Table of Contents

    Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Professional Survey Report 2017
    1 Industry Overview of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    1.1 Definition and Specifications of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    1.1.1 Definition of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    1.1.2 Specifications of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    1.2 Classification of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    1.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
    1.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (%) by Types in 2017
    1.2.3 Serum biomarkers
    1.2.4 Hepatic fibrosis biomarkers
    1.2.5 Apoptosis biomarkers
    1.2.6 Oxidative stress biomarkers
    1.2.7 Others
    1.3 Applications of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    1.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption (K Units) Comparison by Applications (2012-2023)
    1.3.2 Pharma & CRO Industry
    1.3.3 Hospitals
    1.3.4 Diagnostic Labs
    1.3.5 Academic Research Institutes
    1.4 Global NASH (Non-alcoholic Steatohepatitis) BiomarkersMarket by Regions (2012-2023)
    1.4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size and Growth Rate (%) Comparison by Regions (2012-2023)
    1.4.2 North AmericaNASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2012-2023)
    1.4.3 EuropeNASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2012-2023)
    1.4.4 ChinaNASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2012-2023)
    1.4.5 JapanNASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2012-2023)
    1.4.6 Southeast AsiaNASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2012-2023)
    1.5 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (2012-2023)
    1.5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million USD) Status and Outlook (2012-2023)
    1.5.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Capacity, Production (K Units) Status and Outlook (2012-2023)

    2 Industrial Chain Analysis
    2.1 Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    2.2 Raw Material Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    2.2.1 Raw Material A Market Analysis
    2.2.2 Raw Material B Market Analysis
    2.2.3 Raw Material C Market Analysis
    2.3 Labor Cost Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    2.4 Other Costs Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    2.5 Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    2.6 Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    2.7 Raw Materials Sources of NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers in 2017
    2.8 Downstream Buyers of NASH (Non-alcoholic Steatohepatitis) Biomarkers

    3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Profiles/Analysis
    3.1 GENFIT
    3.1.1 Company Basic Information, Manufacturing Base and Competitors
    3.1.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.1.2.1 Serum biomarkers
    3.1.2.2 Hepatic fibrosis biomarkers
    3.1.2.3 Apoptosis biomarkers
    3.1.3 GENFIT 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.1.4 GENFIT 2017 Business Region Distribution Analysis
    3.1.5 GENFIT NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.2 Gilead
    3.2.1 Company Basic Information, Manufacturing Base and Competitors
    3.2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.2.2.1 Serum biomarkers
    3.2.2.2 Hepatic fibrosis biomarkers
    3.2.2.3 Apoptosis biomarkers
    3.2.3 Gilead 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.2.4 Gilead 2017 Business Region Distribution Analysis
    3.2.5 Gilead NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.3 AstraZeneca
    3.3.1 Company Basic Information, Manufacturing Base and Competitors
    3.3.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.3.2.1 Serum biomarkers
    3.3.2.2 Hepatic fibrosis biomarkers
    3.3.2.3 Apoptosis biomarkers
    3.3.3 AstraZeneca 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.3.4 AstraZeneca 2017 Business Region Distribution Analysis
    3.3.5 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.4 Novartis AG
    3.4.1 Company Basic Information, Manufacturing Base and Competitors
    3.4.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.4.2.1 Serum biomarkers
    3.4.2.2 Hepatic fibrosis biomarkers
    3.4.2.3 Apoptosis biomarkers
    3.4.3 Novartis AG 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.4.4 Novartis AG 2017 Business Region Distribution Analysis
    3.4.5 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.5 Bristol-Myers Squibb
    3.5.1 Company Basic Information, Manufacturing Base and Competitors
    3.5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.5.2.1 Serum biomarkers
    3.5.2.2 Hepatic fibrosis biomarkers
    3.5.2.3 Apoptosis biomarkers
    3.5.3 Bristol-Myers Squibb 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.5.4 Bristol-Myers Squibb 2017 Business Region Distribution Analysis
    3.5.5 Bristol-Myers Squibb NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.6 Allergan Novo Nordisk A/S
    3.6.1 Company Basic Information, Manufacturing Base and Competitors
    3.6.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.6.2.1 Serum biomarkers
    3.6.2.2 Hepatic fibrosis biomarkers
    3.6.2.3 Apoptosis biomarkers
    3.6.3 Allergan Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.6.4 Allergan Novo Nordisk A/S 2017 Business Region Distribution Analysis
    3.6.5 Allergan Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.7 Boehringer Ingelheim GmbH
    3.7.1 Company Basic Information, Manufacturing Base and Competitors
    3.7.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.7.2.1 Serum biomarkers
    3.7.2.2 Hepatic fibrosis biomarkers
    3.7.2.3 Apoptosis biomarkers
    3.7.3 Boehringer Ingelheim GmbH 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.7.4 Boehringer Ingelheim GmbH 2017 Business Region Distribution Analysis
    3.7.5 Boehringer Ingelheim GmbH NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.8 Pfizer
    3.8.1 Company Basic Information, Manufacturing Base and Competitors
    3.8.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Category, Application and Specification
    3.8.2.1 Serum biomarkers
    3.8.2.2 Hepatic fibrosis biomarkers
    3.8.2.3 Apoptosis biomarkers
    3.8.3 Pfizer 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.8.4 Pfizer 2017 Business Region Distribution Analysis
    3.8.5 Pfizer NASH (Non-alcoholic Steatohepatitis) Biomarkers Volume in Different Applications and Its Application Share
    3.9.2.1 Serum biomarkers
    3.9.2.2 Hepatic fibrosis biomarkers
    3.9.2.3 Apoptosis biomarkers
    3.10.2.1 Serum biomarkers
    3.10.2.2 Hepatic fibrosis biomarkers
    3.10.2.3 Apoptosis biomarkers

    4 Technical Data and Manufacturing Plants Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    4.1 Capacity and Commercial Production Date of Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers in 2017
    4.2 Manufacturing Plants Distribution of Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers in 2017
    4.4 R&D Status and Technology Source of Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers in 2017
    4.4 Raw Materials Sources Analysis of Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers in 2017

    5 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Overall Market Overview
    5.1 2012-2017 Overall Market Analysis
    5.2 Capacity Analysis
    5.2.1 2012-2017 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Capacity and Growth Rate Analysis
    5.2.2 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Capacity Analysis (Company Segment)
    5.3 Sales Analysis
    5.3.1 2012-2017 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Growth Rate Analysis
    5.3.2 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Analysis (Company Segment)
    5.4 Sales Price Analysis
    5.4.1 2012-2017 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price
    5.4.2 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis (Company Segment)

    6 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Market Analysis
    6.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
    6.1.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Overview
    6.1.2 North America 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Local Supply, Import, Export, Local Consumption Analysis
    6.1.3 North America 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis
    6.1.4 North America 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Analysis
    6.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
    6.2.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Overview
    6.2.2 Europe 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Local Supply, Import, Export, Local Consumption Analysis
    6.2.3 Europe 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis
    6.2.4 Europe 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Analysis
    6.3 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
    6.3.1 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Overview
    6.3.2 China 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Local Supply, Import, Export, Local Consumption Analysis
    6.3.3 China 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis
    6.3.4 China 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Analysis
    6.4 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
    6.4.1 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Overview
    6.4.2 Japan 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Local Supply, Import, Export, Local Consumption Analysis
    6.4.3 Japan 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis
    6.4.4 Japan 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Analysis
    6.5 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
    6.5.1 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Overview
    6.5.2 Southeast Asia 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Local Supply, Import, Export, Local Consumption Analysis
    6.5.3 Southeast Asia 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis
    6.5.4 Southeast Asia 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Analysis
    6.6 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
    6.6.1 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Overview
    6.6.2 India 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Local Supply, Import, Export, Local Consumption Analysis
    6.6.3 India 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Analysis
    6.6.4 India 2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share Analysis

    7 Global 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment Market Analysis (by Type)
    7.1 Global 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type
    7.2 Different Types of NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Interview Price Analysis
    7.3 Different Types of NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Driving Factors Analysis
    7.3.1 Serum biomarkers of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    7.3.2 Hepatic fibrosis biomarkers of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    7.3.3 Apoptosis biomarkers of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    7.3.4 Oxidative stress biomarkers of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    7.3.5 Others of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis

    8 Global 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment Market Analysis (by Application)
    8.1 Global 2012-2017 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Application
    8.2 Different Application of NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Interview Price Analysis
    8.3 Different Application of NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Driving Factors Analysis
    8.3.1 Pharma & CRO Industry of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    8.3.2 Hospitals of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    8.3.3 Diagnostic Labs of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis
    8.3.4 Academic Research Institutes of NASH (Non-alcoholic Steatohepatitis) Biomarkers Growth Driving Factor Analysis

    9 Development Trend of Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers Market
    9.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend Analysis
    9.1.1 Global 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Volume and Value) Forecast
    9.1.2 Global 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price Forecast
    9.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Market Trend
    9.2.1 North America 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast
    9.2.2 Europe 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast
    9.2.3 China 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast
    9.2.4 Japan 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast
    9.2.5 Southeast Asia 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast
    9.2.6 India 2018-2023 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Forecast
    9.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend (Product Type)
    9.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend (Application)

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 NASH (Non-alcoholic Steatohepatitis) Biomarkers Marketing Type Analysis
    11.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Marketing Type Analysis
    11.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers International Trade Type Analysis
    11.3 Traders or Distributors with Contact Information of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Region
    11.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Supply Chain Analysis

    12 Consumers Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    12.1 Consumer 1 Analysis
    12.2 Consumer 2 Analysis
    12.3 Consumer 3 Analysis
    12.4 Consumer 4 Analysis

    13 Conclusion of the Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Professional Survey Report 2018

    14 Methodology and Data Source
    14.1 Methodology/Research Approach
    14.1.1 Research Programs/Design
    14.1.2 Market Size Estimation
    14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
    14.2.1 Secondary Sources
    14.2.2 Primary Sources
    14.3 Disclaimer
    14.4 Author List

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.

Related Products
$2800 - $5500
Publisher : XYZResearch Publication Date : Jul 16, 2018

Number of Pages : 105 Subcategory : Medical Devices
$2800 - $5500
Publisher : XYZResearch Publication Date : Jul 16, 2018

Number of Pages : 129 Subcategory : Medical Devices
$2800 - $5500
Publisher : XYZResearch Publication Date : Jul 16, 2018

Number of Pages : 106 Subcategory : Medical Devices
$2800 - $5500
Publisher : XYZResearch Publication Date : Jul 16, 2018

Number of Pages : 111 Subcategory : Medical Devices